Rheumatic heart disease (RHD) is an autoimmune sequela
|
|
- Ashley Berry
- 5 years ago
- Views:
Transcription
1 HLA Class II Associations With Rheumatic Heart Disease Are More Evident and Consistent Among Clinically Homogeneous Patients Yajaira Guédez, MD; Alyaa Kotby, MD; Maha El-Demellawy, PhD; Ashraf Galal, MD; Glenys Thomson, PhD; Salah Zaher, MD; Samir Kassem, MD; Malak Kotb, PhD Background Discrepancies in reported HLA class II associations with rheumatic heart disease (RHD) may have been due to inaccuracies of serological typing reagents and/or lack of defined clinical classification of patients analyzed. The molecular association between HLA and RHD was investigated in patients with defined clinical outcome. Methods and Results Class II allele/haplotype distribution was determined in 2 groups of RHD patients (n 88) and a control group (n 59). Patients were divided into the mitral valve disease (MVD) category (ie, those with mitral regurgitation with or without mitral stenosis) and the multivalvular lesions (MVL) category, with impairment of aortic and/or tricuspid valves in addition to mitral valve damage. The MVD category (n 65) accounted for 74% of patients and included significantly fewer recurrent RF episodes compared with MVL patients (P 0.002). Conclusions Significant increases in DRB1*0701 and DQA1*0201 alleles and DRB1*0701-DQA1*0201 haplotypes were found in patients. Removal of the MVL patients from analysis increased the strength of HLA associations among the MVD sample. The frequency of DQA1*0103 allele was decreased and the DQB1*0603 allele was absent from the patient group, suggesting that these alleles may confer protective effects against RHD. DQ alleles in linkage disequilibrium with DR alleles appear to influence risk/protection effect: whereas the DRB1*13 DQA1* DQB1*0301 haplotype showed a trend toward risk, the DRB1*13-DQA1*0103-DQB1*0603 haplotype was absent in the RHD sample. Our data indicate that certain class II alleles/haplotypes are associated with risk or protection from RHD and that these associations appear to be stronger and more consistent when analyzed in patients with relatively more homogeneous clinical manifestations. (Circulation. 1999;99: ) Key Words: rheumatic heart disease antigens genetics Rheumatic heart disease (RHD) is an autoimmune sequela of group A streptococcal infections and one of the leading causes of morbidity and mortality in many parts of the world. 1 9 The disease is often preceded by rheumatic fever (RF) episodes that may, in susceptible individuals, progress to a chronic valvular disease. The relatively low attack rate of RF after untreated streptococcal pharyngitis (up to 2% to 3%), 10 the relatively high concordance rate for RF in monozygotic twins (19%) in comparison to dizygotic twins (2.5%), 10 and high familial incidence of RF 11 suggest the involvement of host genetic factors in susceptibility to RF with consequential progression to RHD. Several studies have suggested that genetic susceptibility to RF and RHD is linked to HLA class II alleles However, there has been an apparent discrepancy as to the nature of susceptibility and/or protective alleles. This may have been partly because the majority of investigations used less accurate serological HLA typing methods that can generate false results and fail to discriminate between allelic subgroups. Ethnic differences in the distribution of HLA alleles and the contribution of other genes that could display, in different populations, distinct linkage disequilibrium patterns with HLA DR or DQ alleles may also have contributed to these apparent discrepancies. Another confounding problem was the failure of some studies to separate RF patients with and without carditis or to differentiate between subcategories of RHD for analysis of genetic susceptibility to RHD. Few studies have attempted to analyze the HLA class II associations with specific clinical forms of RHD. 14,20 The question remains as to whether an association between class II allotype and RHD actually exists, and if so, whether it varies for different ethnic groups or is consistent among patients who share the same pattern of valve lesions regardless of their ethnic origin. Received September 22, 1998; revision received February 19, 1999; accepted March 16, From the Veterans Affairs Medical Center (Y.G., M.E., M.K.) and The University of Tennessee, Departments of Surgery, Microbiology, and Immunology (Y.G., M.E., M.K.), Memphis; the Pediatrics Department, Faculty of Medicine, Ain Shams University, Cairo (A.K.) and Alexandria University (A.G., S.Z., S.K.), Egypt; and the Department of Integrative Biology, University of California, Berkeley (G.T.). Correspondence to Malak Kotb, PhD, University of Tennessee, Memphis, 956 Court Ave, Suite A202, Memphis, TN mkotb@utmem1.utmem.edu 1999 American Heart Association, Inc. Circulation is available at
2 Guédez et al June 1, RF is an inflammatory condition that can have different manifestations, including polyarthritis, chorea, and carditis. 24 In most countries, the incidence of carditis in RF patients ranges from 30% to 90%, and the majority of RF patients with carditis develop RHD. 25 In Egypt, for example, the incidence of carditis among RF patients is 60%, and 90% of carditis patients develop RHD. 25 Genetic associations are more likely to be detected in clinically homogeneous groups of patients, and thus it is important to separate carditis patients from patients with other RF sequelae but without carditis. Failure to do so may mask important genetic associations by inclusion of clinically heterogeneous groups. We noted that in studies in which RF patients with carditis were analyzed separately from other RF sequelae or in which only RHD patients, the majority of whom had mitral valve disease (MVD), were studied, the reported HLA associations were rather similar ,18,23 Based on the above observations, we hypothesized that HLA class II associations with RHD may be more consistent if analyzed in patients with relatively homogeneous clinical outcome. We reasoned that by focusing on the RHD patients with documented patterns of mitral valve damage and a history of RF, we would be excluding RF patients without carditis and misdiagnosed patients with RF, which can skew the genetic analyses. Results of the present study support our hypothesis and indicate that certain HLA class II alleles and haplotypes are associated with risk/protection from RHD and that these associations are more evident in patients with MVD. Methods Subjects Two groups of unrelated patients with established RHD (n 88; 59% female, 41% male) from northern Egypt (Cairo and Alexandria) were analyzed both separately by clinic locale and then in combination for the purpose of cross-validation analysis. RHD-1 patients (n 53; mean age, years; 58.5% female and 41.5% male) attended the cardiology clinic at Ain Shams University in Cairo. RHD-2 patients (n 35; mean age, years; 60% female and 40% male) were from El-Shatby Clinic in Alexandria. Patients presented initially with an illness that fulfilled the updated Jones criteria for RF. 24 Diagnosis of valve lesions in follow-up visits was made by echocardiography and/or catheterization. RHD patients were further categorized into MVD (n 65; mean age, years) or multivalvular lesion (MVL; n 20; mean age, years) categories. The MVD category consisted of mitral regurgitation (n 49; 55.7% of all RHD; mean age, years) plus mixed mitral regurgitation mitral stenosis (n 16; 18% of all RHD; mean age, years). The MVD category in the RHD-1 and RHD-2 groups represented 62% (MVD-1) and 91% (MVD-2), respectively. Control subjects were unrelated healthy individuals (n 59; mean age, ; 32% female and 68% male) selected at random from the same geographic area who appeared to be free of autoimmune diseases and had no family history of RF. Internal review board approval (IRB 5938) was obtained for this study. DNA Typing of HLA Class II Genes DNA from whole blood of patients and control subjects was extracted by the Chelex method. 26 Low-resolution HLA-DR typing for DRB1*01 through 18 as well as for DRB3 (DR52), DRB4 (DR53), and DRB5 (DR51) was performed by polymerase chain reaction (PCR) with amplification with sequence-specific primers, 27,28 and 13 DNA control subjects provided by the 12th International Histocompatibility Workshop (IHW) were used as test references. 29 DNA was amplified in a final 50 L of1 PCR buffer (50 mmol/l KCl; 10 mmol/l Tris-HCl, ph 8.3; 0.001% wt/vol gelatin); each reaction mixture contained 200 mol/l of each dntp, 0.4 mol/l DR-specific primers, 0.2 mol/l DR internal control primers, with 1.25 U Taq polymerase (Promega) and 10 to 20 L genomic DNA. Amplification occurred for a total of 33 cycles with 1 minute each of denaturation at 95 C, annealing at 55 C, and extension at 72 C, with the last cycle having an additional 6 minutes of extension at 72 C. PCR products were separated on 2% agarose, the amplified bands were visualized, and the DR type was deduced. High-resolution subtyping of certain DRB1 and all DQB1 alleles was performed with the Innolipa reverse hybridization typing system (Innogenetics) according to the manufacturer s instructions. 30 A nonradioactive oligotyping method was used to examine HLA- DQA1 polymorphism. Primers, probes, and procedures were those indicated in the 12th IHW protocols. 29 Amplified DNA was immobilized on nylon membranes and hybridized with a panel of 19 digoxigenin-labeled probes. An anti digoxigenin alkaline phosphatase Fab antibody fragment (Boehringer Mannheim) was added and bound to any hybrid previously formed. Membranes were incubated with a chemiluminescent substrate (AMPPD, Boehringer Mannheim) and exposed briefly to x-ray films, and reactivity patterns were recorded from the autoradiograph and analyzed. Statistical Analysis HLA-DRB1, DQA1, and DQB1 allele frequencies in patients and healthy unrelated control subjects were compared. Typing of all 3 loci was performed on all patients and control subjects, and haplotype assignments were made with known patterns of linkage disequilibrium in Caucasians 31,32 and were confirmed by family-based genotyping of 12 Egyptian families with 1 to 7 siblings, which generated 11 haplotypes, confirming that the linkage disequilibrium patterns observed were the same as those reported for Caucasians. 31,32 Allele and haplotype frequencies were determined by the method of gene counting. Tests for differences in predisposing and protective effects of HLA class II alleles, haplotypes, and genotypes were performed by use of the odds ratio (OR) method 33 and the relative predispositional effects (RPE) method. 34 Statistical significance was examined by Fisher s exact test. The strength of associations was verified by the cross-validation method 35 (ie, significant associations found in RHD-1 or MVD-1 patients were crossvalidated against RHD-2 or MVD-2 patients, respectively). Crossvalidation against previous studies reporting the same association was also performed. Results Frequency of DRB Alleles in RHD Patients and Control Subjects The frequency of DRB1*0701 was significantly increased in patients over control subjects in the RHD-1 sample (OR 2.3, P 0.03), the RHD-2 sample (OR 2.9, P 0.010), and the combined sample (OR 2.5, P 0.007), where the frequency in patients was 21% compared with 9.3% in control subjects (Table 1). The strength of the DRB1*0701 association increased when the MVD group was analyzed separately (Table 1); the frequency of DRB1*0701 was 24%, compared with 9% in control subjects (OR 3.0, P 0.002), and the significant association of this allele was cross-validated in the MVD-1 and MVD-2 groups (P 0.003, and 0.018, respectively). The frequency of DRB1*0701 in patients with MVL (10%) was lower than in the MVD patients but not significantly different and also was not significantly different from that in control subjects. The DRB1*13 allele showed a trend toward a higher frequency in RHD patients compared with control subjects,
3 2786 HLA Association in RHD TABLE 1. DRB1 Allele Distribution in RHD Patients Compared With Healthy Control Subjects DRB1* Alleles *05 *06 Group *01 *02 *03 *04 *11 *12 *13 *14 *0701 *08 *0901 *1001 RHD 1 gf(p) OR/ (0.030) 2.3/ (n 106) RHD 2 (n 70) gf(p) OR/ (0.012) 0.19/ (0.046) 0.31/ (0.010) 2.9/ All RHD gf(p) OR/ (0.007) 2.5/ (n 176) MVD-1 (n 66) gf(p) OR/ (0.003) 3.4/ MVD-2 (n 64) gf(p) OR/ (0.018) 0.21/ (0.018) 2.72/ All MVD gf(p) OR/ (0.002) 3.0/ (n 130) MVL (n 40) gf(p) OR/ Control subjects gf (n 118) *The asterisk preceding the allele number indicates the allele molecular designation (typing at DNA level). Group: RHD-1/MVD-1 and RHD-2/MVD-2 are RHD or MVD patients (mitral regurgitation [MR] and MR mitral stenosis cases) from Cairo and Alexandria, respectively. MVL indicates multivalvular lesion cases (MR plus aortic and/or tricuspid regurgitation). Bold-face type highlights statistically significant associations for patients vs control subjects. gf (gene frequency), P (probability), OR (odds ratio), and 2 values are reported only for significant associations (P 0.05). n number of haplotypes (eg, 106 haplotypes from 53 individuals). Nature of valve lesion was not reported on 3 patients. whereas the DRB1*10, DRB1*02, and DRB1*11 alleles showed decreased frequencies, particularly in RHD-2 patients. However, neither of these effects was significant or cross-validated, even with RPE analysis after removal of DRB1*0701. Frequency of DQA1 and DQB1 Alleles in RHD Patients and Control Subjects A possible protective effect of DQA1*0103 was seen (Table 2); the frequency of this allele was lower in all RHD patients than in control subjects (P 0.048), with significantly negative association found in the RHD-2 (P 0.001) but not in RHD-1 patients. The strength of the negative association between the DQA1*0103 allele and RHD was increased when the MVD group was analyzed separately (P 0.016) TABLE 2. Distribution of DQA1 Alleles in RHD Patients and Healthy Control Subjects and was strongest in the MVD-2 group (P 0.002), but it was not cross-validated with MVD-1 patients. An increased frequency of DQA1*0201 was seen among patients. The association of DQA1*0201 with risk was stronger in the MVD category (P 0.013), and its significance was cross-validated in the MVD-1 (P 0.03) and MVD-2 (P 0.04) groups (Table 2). RPE analysis failed to reveal further associations after removal of either DQA1*0103 or DQA1*0201 alleles from the analysis. No significant association with either risk or protection was found in the MVL patients; however, the DQA1*0401 allele showed a trend toward increased frequency in this group. Similarly, although the DQA1*0601 allele was completely absent in MVD-1 and MVD-2 patients, it was found with a 3-fold higher frequency in MVL patients than in control DQA1* Alleles Group *0101/4 *0102 *0103 *0201 * *0401 * *0601 RHD 1 (n 106) gf(p) OR/ RHD 2 (n 70) gf(p) OR/ (0.001) 0.05/ (0.026) 2.39/ All RHD (n 176) gf(p) OR/ (0.048) 0.44/ (0.039) 1.93/ MVD-1 (n 66) gf(p) OR/ (0.030) 2.4/ MVD-2 (n 64) gf(p) OR/ (0.002) (0.05/ (0.042) 2.3/ MVD (n 130) gf(p) OR/ (0.016) 0.30/ (0.013) 2.3/ MVL (n 40) gf(p) OR/ Control subjects (n 118) gf *Typing methods did not discriminate between DQA1*0301/0302, DQA1 *0101/0104, or the DQA1 *0501/*0502/*0503. Group: see Table 1 footnote. Bold-face type highlights statistically significant associations for patients vs controls. gf (gene frequency), P (probability), OR (odds ratio), and 2 values are reported only for significant associations (P 0.05). n number of haplotypes (eg, 106 haplotypes from 53 individuals). Nature of valve lesion was not reported on 3 patients.
4 Guédez et al June 1, TABLE 3. Distribution of DQB1 Alleles in RHD Patients and Healthy Control Subjects DQB1* Alleles Group * *0301 *0302 *0303 *0402 *0501 *0601 *0602 *0603 *0604 *0607 Others RHD 1 gf(p) OR/ (0.020) 0.08/ (n 106) RHD 2 (n 70) gf(p) OR/ (0.022) 0.09/ # All RHD gf(p) OR/ (0.004) 0.05/ (n 176) MVD-1 (n 66) gf(p) OR/ # MVD-2 (n 64) gf(p) OR/ (0.029) 0.10/ # MVD (n 130) gf(p) OR/ (0.037) 0.21/ (0.011) 0.07/ MVL (n 40) gf(p) OR/ Control subjects gf (n 118) *Alleles DQB1 *0201/*0202 could not be distinguished and were referred to as DQB1 * Group: see Table 1 footnote. Bold-face type highlights statistically significant associations for patients vs controls. Alleles having a gf 3% in all the groups under study: DQB1 *0502, *0503, *0605, *0608, and *0609. gf (gene frequency) (ie, allele frequency), P, OR, and 2 values are reported only for significant associations (P 0.05). n number of haplotypes (eg, 106 haplotypes from 53 individuals). Nature of valve lesion was not reported on 3 patients. #Despite total absence of this allele, the P values approached but did not reach significance, probably because of sample size (RHD-2, P 0.058; MVD-1, P 0.066; MVD-2, P 0.071). subjects (P NS). The DQB1*0601 allele was absent from only the RHD-2 group (P 0.02) and thus the MVD-2 (P 0.03). Interestingly, the DQB1*0603 allele was completely absent in all patient groups, including patients with MVL, whereas its frequency was 5% in control subjects (P for all RHD and 0.01 for MVD, Table 3). This suggests a protective effect for this allele in RHD. DRB1-DQA1-DQB1 Haplotypes Associated With RHD The DRB1*0701-DQA1*0201 haplotype in this population was in linkage disequilibrium with either the DQB1*0201 or DQB1*0303 alleles and was significantly increased in the combined RHD (P 0.018) and the RHD-2 group (P 0.01), Table 4. This association was stronger in the MVD group (P 0.004) and was cross-validated between the MVD-1 (P 0.012) and the MVD-2 (P 0.018) groups. Predisposing TABLE 4. Significant HLA Haplotype Associations With Predisposition/Protection in RHD Patients effects of DRB1*0701 DQA1*0201 DQB1*0201-2/*0303 haplotypes may have been conferred by DRB1*0701 and/or DQA1*0201 alleles, which were significantly associated with risk in MVD patients. The frequency of DRB1*13 DQA1* DQB1*0301 was higher in all patient categories and was significantly increased in the combined RHD sample (OR 3, P 0.04), Table 4. Removal of the MVL patients increased the strength of this association in the MVD group (P 0.03), with a higher association found in the MVD-2 group (P 0.02). Failure to cross-validate the trend for a predisposing effect of this haplotype may have been related to the sample size. Highresolution subtyping revealed that DRB1*13 suballeles found on this susceptibility haplotype were DRB1*1303, *1304, *1307, *1310, and *1314. Interestingly, the DRB1*13-DQA1*0103-DQB1*0603 haplotype was completely absent in all patient groups, DRB1-DQA1-DQB1 Group *15-*0103-*0601 *0701-*0201-*0201-2/0303 *13-* *0301 *13-*0103-*0603 RHD-1 (n 106) HF(P) OR/ (0.039) 0.09/4.6 RHD-2 (n 70) HF(P) OR/ 2 0 (0.022) 0.06/ (0.010) 2.9/ All RHD (n 176) HF(P) OR/ (0.018) 2.2/ (0.044) 2.9/ (0.009) 0.06/7.6 MVD-1 (n 66) HF(P) OR/ (0.012) 2.9/ MVD-2 (n 64) HF(P) OR/ (0.029) 0.10/ (0.018) 2.72/ (0.022) 4.1/ MVD (n 130) HF(P) OR/ (0.037) 0.21/ (0.004) 2.8/ (0.033) 3.2/ (0.023) 0.08/5.6 MVL (n 40) HF(P) OR/ Control subjects (n 118) HF(P) OR/ Significant increase in the frequency of the DRB1 *0701-DQA1 *0201-DQB1 * haplotype alone was found in all RHD cases (P 0.045) and the MVD group (P 0.014). HF indicates haplotype frequency. The P, OR, and 2 values are reported only for significant associations (P 0.05). n number of haplotypes (eg, 106 haplotypes from 53 individuals). Nature of valve lesion was not reported on 3 patients.
5 2788 HLA Association in RHD TABLE 5. Previously Reported HLA Class II Associations in Patients With RF and RHD HLA Class II Associations Population Risk Protection Method* Clinical Form Patient Age, y (mean SD) No. of Patients No. of Control Subjects North India 21 DR3 Serology RHD Unknown North India 17 DR3 DR2 Serology RHD Unknown DQw2 Black (America) 20 DR2 Serology RHD (MR) Unknown Caucasian (America) 20 DR4 Serology RHD (MR) Unknown Black (South Africa) 23 DR1 Serology RHD (60% MVD) DR6 Caucasian (America) 22 DR4 DR6 Serology RHD Saudi 19 DR4 Serology RHD (MVL) Turkish 16 DR3 DR5 Serology RHD (51% MVD) DR7 Brazilian 18 DR7 Serology RHD/RF (carditis) DR53 Brazilian 15 DR53 RFLP RHD/RF Unknown DR16(2) Japanese 14 DRB1*1405 DQA1*0104 DQB1*0503 PCR-SSO RHD (86% MVD) Mexican 13 DRB1*0301 DRB1*0701 DQB1*0201 whereas its frequency was 4% in control subjects (P 0.009), Table 4. The DRB1*13 suballeles found on this protective haplotype were DRB1*1301, *1308, and *1316. The trend for a protective effect of this haplotype may have been conferred by the DQA1*0103 and/or DQB1*0603 alleles, which were individually associated with protection (Tables 2 and 3). The trend toward protective association with the DRB1*15-DQA1*0103-DQB1*0601 haplotype found in patients from Alexandria (RHD-2/MVD-2) but not Cairo was unexpected because of the ethnic homogeneity between these geographically proximal cities. It is also possible that certain genetic elements are associated with RHD regardless of ethnicity or strain of streptococcus, whereas other elements may be sensitive to differences in the serotypes of streptococcal strains circulating in different communities. Discussion The HLA association in RHD has been investigated in several studies, and although the data seem to support the hypothesis that such a link exists, a consistent association with specific allele(s)/haplotypes was lacking (Table 5). This might be attributable to difficulties associated with serological HLA typing methods used by the majority of these investigations, which can generate false results. For example, recently Ayoub et al 36 found that the previously described DR4 association in Caucasian American RHD patients did not hold when HLA was reassessed by DNA typing methods. Old serological typing reagents did not differentiate between DR allelic splits such as DR13 and DR14, which are splits of PCR-SSO RHD (52% MVD) 75% 40 y *Method: RFLP indicates restriction fragment-length polymorphism; PCR-SSO, PCR and sequence-specific oligonucleotide. MR indicates mitral regurgitation. Bold-face type highlights associations observed in this study. Recently, Ayoub et al 36 found that the previously described association with DR4 did not hold when analysis was performed by molecular typing. DR6, and provided no data on subdivisions of DQA and DQB alleles that are on the same haplotype and that may influence the effect of DR alleles on disease. Therefore, associations apparent only with molecular subdivisions of suballeles were missed. The predisposing/protective effects of particular class II suballeles may have been masked by other suballeles that are not associated with disease, and the differential effect on disease of a particular allele present on distinct haplotypes would not have been detected. In addition to these technical difficulties, different outcomes of RF may be associated with distinct genetic elements, and it is important and useful to analyze clinically homogeneous RF categories separately. The findings of our study (summarized in Table 6) underscore the importance of analyzing genetic association with disease in clinically homogeneous patients by molecular methods. If we focus on RHD patients with MVD, there is a high likelihood that these patients had carditis during their RF attack, and thus misdiagnosed patients or those with other categories of RF without carditis, who may mask genetic associations with RHD, would be excluded from the analysis. This distinction was particularly important in our study because as many as 40% of RF patients in Egypt are without carditis, 25 and this group would have masked the associations detected here. Furthermore, we believe that analysis of MVD and MVL patients separately increases the clinical homogeneity of patients. Indeed, our study shows that HLA associations were stronger when the MVL group was excluded from the analysis. Interestingly, the MVD patients experi-
6 Guédez et al June 1, TABLE 6. Summary of HLA Alleles/Haplotypes Associated With RHD in This Study Risk Protection DRB1*0701 DQA1*0201 DQA1*0103 DQB1*0603 DRB1*0701-DQA1*0201 DRB1*13-DQA1* DQB1*0301 DRB1*13-DQA1*0103-DQB1*0603 *The asterisk preceding the allele number indicates the allele molecular designation (typing at DNA level). Bold-face type highlights associations cross-validated in this study. The associations with DRB1*0701 allele and DRB1*0701-related haplotypes were cross-validated in this study as well as with previous studies in Turkish, Brazilian, and Mexican populations (Table 5). The DR 6 (13) haplotypes showed strong trends toward risk/protection but were not cross-validated in this study. enced a significant 5-fold fewer acute recurrent RF episodes compared with the MVL patients, with mean rates of RF recurrence of 0.7 and 3.3, respectively (P 0.002). In accordance with our hypothesis, studies in which RHD patients were analyzed separately from RF without carditis 15,18 and in which the MVD category accounted for the majority of cases 13,14,16,23 seem to have found similar class II associations with RHD, and these are consistent with the findings reported here (Tables 5 and 6). For example, increased frequencies of DRB1*0701 (DR7), DRB1*0301 (DR3), DR6, and DQB1*0201 alleles were found in RHD patients from different ethnic groups. 13,14,16,18,23 Consistent with these studies, we found a significant increase in the frequency of the DRB1*0701 allele in RHD patients (P 0.007), and this association with risk was even stronger when analysis was focused on the MVD group (P 0.002). Similarly, the entire DRB1*0701-DQA1*0201 haplotype was significantly associated with risk in our entire RHD sample (particularly in combination with DQB1*0201-2), and the strongest association with this haplotype was found in the MVD category (P 0.004). This association was crossvalidated in our MVD-1 and MVD-2 samples and also against previous studies in which the majority of patients had MVD. 13,16,18 Interesting trends and associations were also clustered around the DR6-related haplotypes. The DR6 antigen has 2 phenotypic splits encoded by the DRB1*13 or DRB1*14 alleles, each with several subtypes. In our study, the DRB1*13 DQA1* DQB1*0301 haplotype showed a trend toward association with risk and was significantly increased in patients with MVD. By contrast, the DRB1*13- DQA1*0103-DQB1*0603 haplotype was absent in all patient groups, which suggested a protective influence of this haplotype. An association between DR6 haplotypes and RHD was also reported in other studies. 14,23 Koyanagi et al 14 reported a high frequency of the DRB1*1405-DQA1*0104- DQB1*0503 haplotype in Japanese RHD patients with predominant MVD. A high frequency of DR6 was found in blacks from South Africa 23 (60% with MVD). Interestingly, a negative association between RHD and DR6 was reported in the Utah study 22 ; however, because serological typing was performed and thus no information on DR6 splits, suballeles, or haplotypes was provided, it is possible that the negative association with DR6 was conferred by the DRB1*13- DQA1*0103-DQB1*0603 haplotype, which in our study is showing a protective trend. Therefore, depending on the DR6 splits (DR13 or DR14) or the DRB1*13/DRB1*14 suballeles and the nature of additional elements present on the same haplotype (ie, DQA and DQB alleles), the DR6 haplotypes may either exert risk or confer protection from RHD. More than 1 predisposing allele and haplotype were detected in our study. Although individual alleles on risk haplotypes were significantly associated with RHD, we should not rule out the possibility that other genetic elements on these haplotypes may be more directly involved in disease susceptibility. In the MVD group, the frequencies of DRB1*0701-DQA1*0201 DQB1*0201-2/0303 and DRB1*13 DQA1* DQB1*0301 haplotypes were 22% and 10%, compared with 9% and 3% in control subjects, respectively. These levels of frequencies reported here as well as in Japanese 14 and Mexican 13 patients are to be expected for autoimmune diseases of infectious origin in which variations in the microorganisms in this case differences in serotype of group A streptococcal strains may influence outcome. Inasmuch as different microbe-derived autoimmunogenic peptides may be differentially presented by distinct alleles, HLA associations may become more evident if sorted by the nature of peptide binding motifs. 37,38 In analyzing the role of class II alleles/haplotypes in various diseases, it is important to consider that protective associations are equally, if not more, relevant than predisposing associations. For example, DQB1*0302 and DQB1*0201, which pose a strong risk in insulin-dependent diabetes, lack the protective Asp57 found in DQB1*0301, DQB1*0303, and DQB1*0401 alleles and especially in DQB1*0602, which confers protection even among relatives of insulindependent diabetes. 39 HLA alleles regulate immune responses to infections, 35 bind and present autoantigens with different affinities, play a role in T-cell repertoire selection, 40 and may themselves be target autoantigens. 39,41,42 Differential presentation of autoimmune peptides by protective and nonprotective or susceptibility alleles can have major effects on the development of pathogenic autoimmunity. Future structure function studies may reveal mechanisms by which certain alleles (eg, DQB1*0603) and the DRB1*13- DQA1*0103-DQB1*0603 haplotype may confer protection in RHD. In conclusion, our data support the hypothesis that apparent discrepancies among some studies investigating HLA class II associations with RHD might have been due, in part, to an inappropriate grouping of RF with and without carditis and/or heterogeneous clinical subgroups of RHD patients. It should be noted that the results from our study showing that the DRB1*0701-, DR6-, and DQB1*0201-related haplotypes confer susceptibility to MVD are in agreement with those reported for populations of Turkish, 16 Mexican, 13 South African, 23 and Japanese 14 RHD patients, in whom the MVD category constituted the majority of cases ( 50%). The data presented here suggest that the identification of class II allele haplotypes may provide an insight into the molecular mechanism of the disease and may be a useful tool in predicting the clinical outcome in RF patients, thereby affording new means of intervention or vaccine design.
7 2790 HLA Association in RHD Acknowledgments This work was supported by grants from the US Veterans Administration (Dr Kotb) and the National Institutes of Health (NIH AI to Dr Kotb and GM to Dr Thomson). Dr El-Demellawy was supported, in part, by the W.S. Fulbright Commission. References 1. Markowitz M, Gerber MA. The Jones criteria for guidance in the diagnosis of rheumatic fever: another perspective. Arch Pediatr Adolesc Med. 1995;149: Stollerman GH. Rheumatic fever. Lancet. 1997;349: Shulman ST. Complications of streptococcal pharyngitis. Pediatr Infect Dis J. 1994;13(suppl 1):S70 S Kaplan EL. Global assessment of rheumatic fever and rheumatic heart disease at the close of the century: influences and dynamics of populations and pathogens: a failure to realize prevention? Circulation. 1993; 88: Bisno AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med. 1991;325: Zabriskie JB, Gibofsky A. Genetic control of the susceptibility to infection with pathogenic bacteria. Curr Top Microbiol Immunol. 1986; 124: Ayoub EM. Acute rheumatic fever. In: Emmanouilides GC, Riemenschneider TA, Allen HD, Gutgesell HP, eds. Heart Disease in Infants, Children, and Adolescents. 5th ed. Baltimore, Md: Williams & Wilkins; 1995: Veasy LG, Hill HR. Immunologic and clinical correlations in rheumatic fever and rheumatic heart disease. Pediatr Infect Dis J. 1997;16: Sanyal SK. Long-term sequelae of the first attack of acute rheumatic fever during childhood. In: Emmanouilides GC, Riemenschneider TA, Allen HD, Gutgesell HP, eds. Heart Disease in Infants, Children and Adolescents. 5th ed. Baltimore, Md: Williams & Wilkins; 1995: DiSciascio G, Taranta A. Rheumatic fever in children. Am Heart J. 1980;99: Pickles WN. Rheumatic family. Lancet. 1943;2: Monplaisir N, Valette I, Bach J-F. HLA antigens in 88 cases of rheumatic fever observed in Martinique. Tissue Antigens. 1986;28: Debaz H, Olivo A, Perez-Luque E, Vasquez-Garcia MN, Burguete A, Chavez-Negrete A, Velasco C, Arguero R, Gorodeszky C. DNA Analysis of class II alleles in rheumatic heart disease in Mexicans. 22nd Annual ASHI Meeting Abstracts. Human Immunology. 1996;49(suppl): Koyanagi T, Koga Y, Nishi H, Toshima H, Sasazuki T, Imaizumi T, Kimura A. DNA typing of HLA class II genes in Japanese patients with rheumatic heart disease. J Mol Cell Cardiol. 1996;28: Weidebach W, Goldberg AC, Chiarella JM, Guilherme L, Snitcowsky R, Pileggi F, Khalil J. HLA class II antigens in rheumatic fever: analysis of the DR locus by restriction fragment-length polymorphism and oligotyping. Hum Immunol. 1994;40: Ozkan M, Carin M, Sonmez G, Senocak M, Ozdemir M, Yakut C. HLA antigens in Turkish race with rheumatic heart disease. Circulation. 1993; 87: Taneja V, Mehra NK, Reddy S, Narula J, Tandon R, Vaidya MC, Bhatia ML. HLA-DR/DQ antigens and reactivity to B cell alloantigen D8/17 in Indian patients with rheumatic heart disease. Circulation. 1989;80: Guilherme L, Weidebach W, Kiss MH, Snitcowsky R, Khalil J. Association of human leukocyte class II antigens with rheumatic heart disease in Brazilian population. Circulation. 1991;83: Rajapakse CNA, Halim K, Al-Orainey I, Al-Nozha M, Al-Aska AK. A genetic marker for rheumatic heart disease. Br Heart J. 1987;58: Ayoub EM, Barret DJ, Maclaren NK, Krischer JP. Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest. 1986;77: Jhinghan B, Mehra NK, Reddy KS, Taneja V, Vaidya MC, Bhatia ML. HLA, blood groups and secretor status in patients with established rheumatic heart disease. Tissue Antigens. 1986;27: Anastasiou-Nana MI, Anderson JL, Carquist JF, Nanas JN. HLA-DR typing and lymphocyte subset evaluation in rheumatic heart disease: a search for immune response factors. Am Heart J. 1986;112: Maharaj B, Hammond MG, Appadoo B, Leary WP, Phil D, Pudifin DJ. HLA-A, B, DR, and DQ antigens in black patients with severe chronic rheumatic heart disease. Circulation. 1987;76: Dajani AS, Bisno AL, Chung KJ, Durack DT, Gerber MA, Kaplan EL, Millard HD, Randolph MF, Shulman ST, Watanakunakorn C. Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA. 1992;268: Kotby AA, El-Monim MTA, Hassan AS. Assessment of rheumatic fever and rheumatic heart disease in the Children s Hospital of Ain Shams University from Egypt J Pediatr. 1996;13: Walsh PS, Metzger DA, Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques. 1991;10: Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens. 1992;39: Olerup O, Zetterquist H. DR low-resolution PCR-SSP typing: a correction and an up-date. Tissue Antigens. 1993;41: Bignon JD, Fernandez-Vina MA, Cheneau ML, Faucet R, Schreuder GMT, Clayton J, Marsh SGE, Charron D. HLA DNA class II typing by PCR-SSOP: 12th International Histocompatibility Workshop experience. In: Charron D, ed. HLA: Genetic Diversity of HLA: Functional and Medical Implications. Paris, France: EDK; 1997: Buyse I, Decorte R, Baens M, Cuppens H, Semana G, Emonds MP, Marynen P, Cassiman JJ. Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization. Tissue Antigens. 1993;41: Hors J, El Chenawi S, Djoulah S, Hafez M, Abbas F, El Borai MH, Kamel M, Abbal M, Cambon-Thomsen A, Mercier P, Reviron D, Magzoub MA, Rosner G, Delgado JC, Yunis E, Raffoux C, Tamouza R, Izaabel H, Hmida S, Benhamamouch S, Bessaoud K, Langaney A, Sanchez-Mazas A. HLA in North African populations: 12th International Histocompatibility Workshop NAFR report. In: Charron D, ed. HLA: Genetic Diversity of HLA: Functional and Medical Implications. Paris, France: EDK; 1997: Fernandez-Viña MA, Gao X, Moraes ME, Moraes JR, Salatiel I, Miller S, Tsai J, Sun Y, An J, Layrisse Z, Gazit E, Brautbar C, Stastny P. Alleles at four HLA class II loci determined by oligonucleotide hybridization and their associations in five ethnic groups. Immunogenetics. 1991;34: Woolf B. On estimating the relation between blood groups and disease. Ann Hum Genet. 1955;19: Payami H, Khan MH, Grennan DM, Sanders PA, Dyer PA, Thomson G. Analysis of genetic interrelationship among HLA-associated diseases. Am J Hum Genet. 1987;41: Hill AVS. HLA and infection. J R Coll Physicians Lond. 1992;26: Ayoub EM, Kotb M, Cunningham MW. Rheumatic fever pathogenesis. In: Stevens DL, Kaplan EL, eds. Streptococcal Infections. New York, NY: Oxford University Press: In press. 37. Thorsby E. HLA associated diseases. A summary of the 12th International Histocompatibility workshop component. In: Charron D, ed. HLA: Genetic Diversity of HLA: Functional and Medical Implications. Paris, France: EDK; 1996: Kotb M. Infection and autoimmunity: a story of the host, the pathogen, and the copathogen. Clin Immunol Immunopathol. 1995;74: Nepom GT. Class II antigens and disease susceptibility. Annu Rev Med. 1995;46: Schmidt D, Verdager J, Nuzhat A, Santamaria P. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J Exp Med. 1997;186: Sinha AA, Lopez MT, McDevit HO. Autoimmune diseases: the failure of self tolerance. Science. 1990;248: McDevitt HO, Chinitz A. Genetic control of the antibody response: relationship between immune responses and histocompatibility (H-2) type. Science. 1969;163:
Received: 2 Jan 2003 Revisions requested: 3 Mar 2003 Revisions received: 11 Aug 2003 Accepted: 15 Aug 2003 Published: 8 Sep 2003
Research article HLA class II associations with rheumatic heart disease among clinically homogeneous patients in children in Latvia Valda Stanevicha 1, Jelena Eglite 2, Arturs Sochnevs 2, Dace Gardovska
More informationHLA-A, B, DR, and DQ Antigens in Indian Patients with Severe Chronic Rheumatic Heart Disease
HLA-A, B, DR, and DQ Antigens in Indian Patients with Severe Chronic Rheumatic Heart Disease Breminand MAHARAJ, MD, Shaun M. KHEDUN, M Med Sci, Michael G. HAMMOND, DSc, and Kenneth van der Byl, BSc R SUMMARY
More informationHLA-DR/DQ Antigens and Reactivit Cell Alloantigen D8/17 in Indian Patients With Rheumatic Heart Disease
335 HLA-DR/DQ Antigens and Reactivit Cell Alloantigen D8/17 in Indian Patients With Rheumatic Heart Disease to B Veena Taneja, MSc, Narinder K. Mehra, PhD, K. Srinath Reddy, MD, DM, Jagat Narula, MD, DM,
More informationImmune Response Factors in Rheumatic Heart Disease: Meta-Analysis of HLA-DR Associations and Evaluation of Additional Class II Alleles
452 JACC Vol. 26, No. 2 VALVIILAR HE.M~T DISEASE Immune Response Factors in Rheumatic Heart Disease: Meta-Analysis of HLA-DR Associations and Evaluation of Additional Class II Alleles JOHN F. CARLQUIST,
More informationT Cell Response in Rheumatic Fever: Crossreactivity Between Streptococcal M Protein Peptides and Heart Tissue Proteins
Current Protein and Peptide Science, 2007, 8, 39-44 39 T Cell Response in Rheumatic Fever: Crossreactivity Between Streptococcal M Protein Peptides and Heart Tissue Proteins Luiza Guilherme 1,2 *, Kellen
More informationASSESSMENT OF THE RISK FOR TYPE 1 DIABETES MELLITUS CONFERRED BY HLA CLASS II GENES. Irina Durbală
ASSESSMENT OF THE RISK FOR TYPE 1 DIABETES MELLITUS CONFERRED BY HLA CLASS II GENES Summary Irina Durbală CELL AND MOLECULAR BIOLOGY DEPARTMENT FACULTY OF MEDICINE, OVIDIUS UNIVERSITY CONSTANŢA Class II
More informationAssociation of HLA-DRB alleles and pulmonary tuberculosis in North Chinese patients
Association of HLA-DRB alleles and pulmonary tuberculosis in North Chinese patients G.L. Shi, X.L. Hu, L. Yang, C.L. Rong, Y.L. Guo and C.X. Song Department of Clinical Immunology Laboratory, Beijing Tuberculosis
More informationGenetics and Genomics in Medicine Chapter 8 Questions
Genetics and Genomics in Medicine Chapter 8 Questions Linkage Analysis Question Question 8.1 Affected members of the pedigree above have an autosomal dominant disorder, and cytogenetic analyses using conventional
More informationCRITICAL REVIEW Valerie Ng, Ph.D., M.D. January, Anti-A Antibody
CRITICAL REVIEW Valerie Ng, Ph.D., M.D. January, 1985 Anti-A Antibody Case Presentation A recently immigrated 7 year old Filipino female, in her usual state of health, was referred for evaluation of an
More informationThe Human Major Histocompatibility Complex
The Human Major Histocompatibility Complex 1 Location and Organization of the HLA Complex on Chromosome 6 NEJM 343(10):702-9 2 Inheritance of the HLA Complex Haplotype Inheritance (Family Study) 3 Structure
More information/01/$ DOI: /IAI Copyright 2001, American Society for Microbiology. All Rights Reserved.
INFECTION AND IMMUNITY, Sept. 2001, p. 5345 5351 Vol. 69, No. 9 0019-9567/01/$04.00 0 DOI: 10.1128/IAI.69.9.5345 5351.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. T-Cell
More informationIndian Journal of Nephrology Indian J Nephrol 2001;11: 88-97
88 Indian Journal of Nephrology Indian J Nephrol 2001;11: 88-97 ARTICLE HLA gene and haplotype frequency in renal transplant recipients and donors of Uttar Pradesh (North India) S Agrawal, AK Singh, RK
More informationHLA-A*26 and Susceptibility of Iranian Patients with Non-Hodgkin Lymphoma
HLA-A*26 and Susceptibility of Iranian Patients with Non-Hodgkin Lymphoma Arezou Sayad 1, Mohammad Taghi Akbari 2**, Mahshid Mehdizadeh 3,4, Mohammad Taheri 1, Abbas Hajifathali 3* 1 Department of Medical
More informationDQA1 and DQB1 Promoter diversity and linkage disequilibrium with class II haplotypes in Mexican Mestizo population
(2001) 2, 216 221 2001 Nature Publishing Group All rights reserved 1466-4879/01 $15.00 www.nature.com/gene DQA1 and DQB1 Promoter diversity and linkage disequilibrium with class II haplotypes in Mexican
More informationHLA class II DRB1 and DQB1 allelic polymorphism and sclerosing lymphocytic lobulitis of the breast
J Clin Pathol 1999;52:445 449 445 Department of Histopathology, Southampton University Hospitals, Southampton, UK A C Bateman J M Theaker Wessex Histocompatibility Laboratory, Southampton University Hospitals
More informationCompleting the CIBMTR Confirmation of HLA Typing Form (Form 2005)
Completing the CIBMTR Confirmation of HLA Typing Form (Form 2005) Stephen Spellman Research Manager NMDP Scientific Services Maria Brown Scientific Services Specialist Data Management Conference 2007 1
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/49010 holds various files of this Leiden University dissertation. Author: Heide, A. van der Title: Unravelling narcolepsy : from pathophysiology to measuring
More informationHUMAN LEUCOCYTE ANTIGEN (HLA) CLASS I AND II FREQUENCIES IN SELECTED GROUPS IN LEBANON
Journal Scientifique Libanais, Vol. 1, No. 1, 2000 119 HUMAN LEUCOCYTE ANTIGEN (HLA) CLASS I AND II FREQUENCIES IN SELECTED GROUPS IN LEBANON Alexander M. Abdelnoor, May Abdelnoor, Walid Heneine, Firas
More informationHuman leukocyte antigen-b27 alleles in Xinjiang Uygur patients with ankylosing spondylitis
Human leukocyte antigen-b27 alleles in Xinjiang Uygur patients with ankylosing spondylitis H.-Y. Zou, W.-Z. Yu, Z. Wang, J. He and M. Jiao Institute of Clinical Medicine, Urumqi General Hospital, Lanzhou
More informationDiversity and Frequencies of HLA Class I and Class II Genes of an East African Population
Open Journal of Genetics, 2014, 4, 99-124 Published Online April 2014 in SciRes. http://www.scirp.org/journal/ojgen http://dx.doi.org/10.4236/ojgen.2014.42013 Diversity and Frequencies of HLA Class I and
More informationDEFINITIONS OF HISTOCOMPATIBILITY TYPING TERMS
DEFINITIONS OF HISTOCOMPATIBILITY TYPING TERMS The definitions below are intended as general concepts. There will be exceptions to these general definitions. These definitions do not imply any specific
More informationRheumatic heart disease
Rheumatic heart disease What will we discuss today? Etiology and epidemiology of rheumatic heart disease Pathogenesis of rheumatic heart disease Morphological changes in rheumatic heart disease Clinical
More informationHandling Immunogenetic Data Managing and Validating HLA Data
Handling Immunogenetic Data Managing and Validating HLA Data Steven J. Mack PhD Children s Hospital Oakland Research Institute 16 th IHIW & Joint Conference Sunday 3 June, 2012 Overview 1. Master Analytical
More informationPrevention of rheumatic fever Rahman MT, Haque KMHSS
Prevention of rheumatic fever Rahman MT, Haque KMHSS The ORION Medical Journal 2006 Sep;25:400-402 Introduction Rheumatic fever is an inflammatory disease that occurs as a delayed nonsuppurative sequel
More informationHistocompatibility Evaluations for HSCT at JHMI. M. Sue Leffell, PhD. Professor of Medicine Laboratory Director
Histocompatibility Evaluations for HSCT at JHMI M. Sue Leffell, PhD Professor of Medicine Laboratory Director JHMI Patient Population Adults Peds NMDP data >20,000 HSCT JHMI HSCT Protocols Bone marrow
More informationProfiling HLA motifs by large scale peptide sequencing Agilent Innovators Tour David K. Crockett ARUP Laboratories February 10, 2009
Profiling HLA motifs by large scale peptide sequencing 2009 Agilent Innovators Tour David K. Crockett ARUP Laboratories February 10, 2009 HLA Background The human leukocyte antigen system (HLA) is the
More informationRelationship Between HLA-DMA, DMB Alleles and Type 1 Diabetes in Chinese
HK J Paediatr (new series) 2005;10:20-25 Relationship Between HLA-DMA, DMB Alleles and Type 1 Diabetes in Chinese YM SANG, C YAN, C ZHU, GC NI, YM HU Abstract Key words The Human Leucocyte Antigen (HLA)-DMA
More informationPolymerase chain reaction based human leucocyte antigen genotyping for the investigation of suspected gastrointestinal biopsy contamination
Gut 1999;45:259 263 259 Histopathology, Southampton General Hospital, Southampton, UK A C Bateman J M Theaker Histocompatibility and Immunogenetics Laboratory, Southampton General Hospital, Southampton,
More informationEchocardiographic Diagnosis of Rheumatic Heart Disease
Echocardiographic Diagnosis of Rheumatic Heart Disease Nigel Wilson Paediatric Cardiologist Paediatric and Congenital Cardiac Services Auckland City and Starship Hospitals Auckland, New Zealand Auckland
More informationRheumatic heart disease in Uganda: the association between MHC class II HLA DR alleles and disease: a case control study
Okello et al. BMC Cardiovascular Disorders 2014, 14:28 RESEARCH ARTICLE Open Access Rheumatic heart disease in Uganda: the association between MHC class II HLA DR alleles and disease: a case control study
More informationHLA and new technologies. Vicky Van Sandt
HLA and new technologies. Vicky Van Sandt Life-threatning malignant and non malignant blood disorders can be cured by hematopoetic stem cell transplantation (HSCT). GVHD is the 2nd most prevalent cause
More informationAntigen Presentation to T lymphocytes
Antigen Presentation to T lymphocytes Immunology 441 Lectures 6 & 7 Chapter 6 October 10 & 12, 2016 Jessica Hamerman jhamerman@benaroyaresearch.org Office hours by arrangement Antigen processing: How are
More informationDocumentation of Changes to EFI Standards: v 5.6.1
Modified Standard B - PERSONNEL QUALIFICATIONS B1.000 The laboratory must employ one or more individuals who meet the qualifications and fulfil the responsibilities of the Director/Co-Director, Technical
More informationAllele and Haplotype Frequencies of Human Leukocyte Antigen-A, -B, -C, -DRB1, and -DQB1 From Sequence- Based DNA Typing Data in Koreans
Original Article Diagnostic Immunology Ann Lab Med 2015;35:429-435 http://dx.doi.org/10.3343/alm.2015.35.4.429 ISSN 2234-3806 eissn 2234-3814 Allele and Haplotype Frequencies of Human Leukocyte Antigen-A,
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/20898 holds various files of this Leiden University dissertation. Author: Jöris, Monique Maria Title: Challenges in unrelated hematopoietic stem cell transplantation.
More informationTuberculosis (TB) is still an important world
Human Leukocyte Antigen-Associated Susceptibility to Pulmonary Tuberculosis* Molecular Analysis of Class II Alleles by DNA Amplification and Oligonucleotide Hybridization in Mexican Patients David Terán-Escandón,
More informationLack of association of IL-2RA and IL-2RB polymorphisms with rheumatoid arthritis in a Han Chinese population
Lack of association of IL-2RA and IL-2RB polymorphisms with rheumatoid arthritis in a Han Chinese population J. Zhu 1 *, F. He 2 *, D.D. Zhang 2 *, J.Y. Yang 2, J. Cheng 1, R. Wu 1, B. Gong 2, X.Q. Liu
More informationRheumatic Fever and Rheumatic Heart Disease: Genetics and Pathogenesis
REVIEW doi: 10.1111/j.1365-3083.2007.01974.x Rheumatic Fever and Rheumatic Heart Disease: Genetics and Pathogenesis L. Guilherme*,, R. Ramasawmy*, & J. Kalil*,,à *Heart Institute (InCor), School of Medicine,
More informationKey words: genotyping/hla-dq/hla-dr/lichen sclerosus/susceptibility J Invest Dermatol 125: , 2005
The Association Between HLA DR, DQ Antigens, and Vulval Lichen Sclerosus in the UK: HLA DRB1 12 and its Associated DRB1 12/DQB1 0301/04/09/010 Haplotype Confers Susceptibility to Vulval Lichen Sclerosus,
More informationPattern of Acute Rheumatic Fever in a Local Teaching Hospital
Pattern of Acute Rheumatic Fever in a Local Teaching Hospital A Omar, FRCP Department of Paediatrics, Faculty of Medicine, University of Malaya, 59700 Kuala Lumpur Introduction Acute rheumatic fever (ARF)
More informationthe HLA complex Hanna Mustaniemi,
the HLA complex Hanna Mustaniemi, 28.11.2007 The Major Histocompatibility Complex Major histocompatibility complex (MHC) is a gene region found in nearly all vertebrates encodes proteins with important
More informationHLA Mismatches. Professor Steven GE Marsh. Anthony Nolan Research Institute EBMT Anthony Nolan Research Institute
HLA Mismatches Professor Steven GE Marsh HLA Mismatches HLA Genes, Structure, Polymorphism HLA Nomenclature HLA Mismatches in HSCT Defining a mismatch HLA Mismatches HLA Genes, Structure, Polymorphism
More informationIMMUNOLOGY. Elementary Knowledge of Major Histocompatibility Complex and HLA Typing
IMMUNOLOGY Elementary Knowledge of Major Histocompatibility Complex and HLA Typing Tapasya Srivastava and Subrata Sinha Department of Biochemistry All India Institute of Medical Sciences New Delhi - 110029
More informationHuman leukocyte antigen (HLA) system
Is HLA a determinant of prognosis or therapeutic response to cytokines, IFN and anti-ctla4 blocking antibodies in melanoma? Helen Gogas, M.D. Ass. Professor in Medical Oncology 1st Department of Medicine,
More informationMulti-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis
JCM Accepts, published online ahead of print on 30 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.00678-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Multi-clonal origin
More informationComplex HLA-DR and -DQ Interactions Confer Risk of Narcolepsy- Cataplexy in Three Ethnic Groups
Am. J. Hum. Genet. 68:686 699, 001 Complex HLA-DR and -DQ Interactions Confer Risk of Narcolepsy- Cataplexy in Three Ethnic Groups Emmanuel Mignot, 1 Ling Lin, 1 William Rogers, 1 Yutaka Honda 4 Xiaohong
More informationAn association analysis of the HLA gene region in latent autoimmune diabetes in adults
Diabetologia (2007) 50:68 73 DOI 10.1007/s00125-006-0513-z SHORT COMMUNICATION An association analysis of the HLA gene region in latent autoimmune diabetes in adults M. Desai & E. Zeggini & V. A. Horton
More informationTCR-p-MHC 10/28/2013. Disclosures. Rheumatoid Arthritis, Psoriatic Arthritis and Autoimmunity: good genes, elegant mechanisms, bad results
Rheumatoid Arthritis, Psoriatic Arthritis and Autoimmunity: good genes, elegant mechanisms, bad results The meaning and significance of HLA associations Disclosures No relevant commercial relationships
More informationSHORT COMMUNICATION UNUSUAL HLA TYPING IN CELIAC DISEASE
DISEASE MARKERS, VOL. 13,61-64 (1996) SHORT COMMUNICATION UNUSUAL HLA TYPING IN CELIAC DISEASE R. GRILLO*, F. PETRONZELU*, P. FERRANTE*, B. MORA*, M. BONAMICO t, M.e. MAZZILU* *Department of Experimental
More informationHuman Leukocyte Antigens and donor selection
Human Leukocyte Antigens and donor selection Duangtawan Thammanichanond, MD. PhD. Histocompatibility and Immunogenetics Laboratory, Faculty of Medicine Ramathibodi Hospital, Mahidol University Outline
More informationMinimal Requirements for Histocompatibility & Immunogenetics Laboratory
Minimal Requirements for Histocompatibility & Immunogenetics Laboratory The 4 th WBMT Congress and Workshop Riyadh, KSA - January 15-17, 2017 HLA Discovery, 1958 The Nobel Prize in Physiology or Medicine
More informationVALVULAR HEART DISEASE
VALVULAR HEART DISEASE Stenosis: failure of a valve to open completely, obstructing forward flow. - almost always due to a chronic process (e.g., calcification or valve scarring). Insufficiency : failure
More informationHLA haplotype A33-B58-Cw10 may modulate radiographic development of bamboo spine in Taiwanese patients with primary ankylosing spondylitis
Disease Markers 26 (2009) 93 96 93 DOI 10.3233/DMA-2009-0619 IOS Press HLA haplotype A33-B58-Cw10 may modulate radiographic development of bamboo spine in Taiwanese patients with primary ankylosing spondylitis
More informationGenotyping of HLA-class-I by PCR-SSP of Iraqi Breast Cancer Patients
Genotyping of HLA-class-I by PCR-SSP of Iraqi Breast Cancer Patients Ahmed A.Al-Hassan 1 PhD, Nidhal Abdul Muhymen 1 MSc;PhD,Ala'a Ghany Hussien 2 FICMS, Ameera J. Al-Nema 3 MBChB. Abstract Background:
More informationRole of NMDP Repository in the Evolution of HLA Matching and Typing for Unrelated Donor HCT
Role of NMDP Repository in the Evolution of HLA Matching and Typing for Unrelated Donor HCT Stephen Spellman, MBS Director, Immunobiology and Observational Research Assistant Scientific Director CIBMTR,
More informationDistribution of HLA Antigens Class I and II in Iraqi Arab population
Distribution of HLA s Class I and II in Iraqi Arab population *Ahmed A.A. Al-Hassan, MSc, Immunology ; **Sana a Al-Naseri, MD, ph.d, immunopathology *** Batool H. Al-Ghurabi, ph.d, Immunology **** Mohammed
More informationResearch: Genetics HLA class II gene associations in African American Type 1 diabetes reveal a protective HLA-DRB1*03 haplotype
Research: Genetics HLA class II gene associations in African American Type 1 diabetes reveal a protective HLA-DRB1*03 haplotype J. M. M. Howson 1,2, M. S. Roy 3, L. Zeitels 1, H. Stevens 1 and J. A. Todd
More informationAntistreptolysin O titer in health and disease: levels and significance
Antistreptolysin O titer in health and disease: levels and significance Alyaa Amal Kotby, Nevin Mamdouh Habeeb, Sahar Ezz El Elarab Pediatric Department, Ain Shams University, Early Cancer Detection Unit
More informationValidation of the MIA FORA NGS FLEX Assay Using Buccal Swabs as the Sample Source
S. Krishnakumar, M. Li, C. Wang, M, Osada, R. Kuehn, M. Fukushima and Y. Thorstenson Immucor, Inc. S. Krishnakumar, M. Li, C. Wang, M, Osada, R. Kuehn, M. Fukushima and Y. Thorstenson Immucor, Inc. Introduction
More informationTransplantation. Immunology Unit College of Medicine King Saud University
Transplantation Immunology Unit College of Medicine King Saud University Objectives To understand the diversity among human leukocyte antigens (HLA) or major histocompatibility complex (MHC) To know the
More informationAnalysis of HLA-A, HLA-B and HLA-DRB1 alleles in Chinese patients with lung cancer
Analysis of HLA-A, HLA-B and HLA-DRB1 alleles in Chinese patients with lung cancer L. Yang 1, L.J. Wang 3, G.L. Shi 2, L. Ni 3, C.X. Song 2, Z.X. Zhang 3 and S.F. Xu 1 1 Department of Thoracic Surgeon,
More information25/10/2017. Clinical Relevance of the HLA System in Blood Transfusion. Outline of talk. Major Histocompatibility Complex
Clinical Relevance of the HLA System in Blood Transfusion Dr Colin J Brown PhD FRCPath. October 2017 Outline of talk HLA genes, structure and function HLA and immune complications of transfusion TA-GVHD
More information10/18/2012. A primer in HLA: The who, what, how and why. What?
A primer in HLA: The who, what, how and why What? 1 First recognized in mice during 1930 s and 1940 s. Mouse (murine) experiments with tumors Independent observations were made in humans with leukoagglutinating
More informationANALYSIS OF IL17 AND IL17RA POLYMORPHISMS IN SPANISH PSORIASIS PATIENTS: ASSOCIATION WITH RISK FOR DISEASE.
ANALYSIS OF IL17 AND IL17RA POLYMORPHISMS IN SPANISH PSORIASIS PATIENTS: ASSOCIATION WITH RISK FOR DISEASE. Batalla A, Coto E*, González-Lara L, González- Fernández D, Maldonado-Seral C, García-García
More informationNarcolepsy with Cataplexy: An Autoimmune Phenomenon
Fall 2014 Meeting October 3-4, 2014 Narcolepsy with Cataplexy: An Autoimmune Phenomenon Soumya C. Madala MD Mercy Health Sleep Center Grand Rapids, MI Conflict of Interest Disclosures for Speakers 1. I
More informationHLA Class I and II Genotyping by PCR-SSO in Patients with Type-1 Diabetes Mellitus
HLA THE CLASS IRAQI POSTGRADUATE I AND II GENOTYPING MEDICAL JOURNAL HLA Class I and II Genotyping by PCR-SSO in Patients with Type-1 Diabetes Mellitus Ahmed A. Al-Hassan*, Anwar Mohammad*, Batool H. Al-Ghurabi**,
More informationNovel HLA Class I Alleles Associated with Indian Leprosy Patients
Biomedicine and Biotechnology 2003:3 (2003) 208 211 PII. S1110724303210019 http://jbb.hindawi.com RESEARCH ARTICLE Novel HLA Class I Alleles Associated with Indian Leprosy Patients U. Shankarkumar, K.
More informationRobert B. Colvin, M.D. Department of Pathology Massachusetts General Hospital Harvard Medical School
Harvard-MIT Division of Health Sciences and Technology HST.035: Principle and Practice of Human Pathology Dr. Robert B. Colvin Transplantation: Friendly organs in a hostile environment Robert B. Colvin,
More informationMolDX: HLA-DQB1*06:02 Testing for Narcolepsy
MolDX: HLA-DQB1*06:02 Testing for Narcolepsy CGS Administrators, LLC Jump to Section... Please Note: This is a Proposed LCD. Proposed LCDs are works in progress and not necessarily a reflection of the
More informationHLA-DQA1 and DQB1 Genotyping in Individuals with Family History of Gastritis
ADVANCES IN BIORESEARCH, Vol. 2 [1] June 2011: 40-46 Society of Education, India http://www.soeagra.com/abr.htm ISSN 0976-4585 RESEARCH ARTICLE HLA-DQA1 and DQB1 Genotyping in with Family Nibras S. Al-Ammar
More informationTopic (Final-03): Immunologic Tolerance and Autoimmunity-Part II
Topic (Final-03): Immunologic Tolerance and Autoimmunity-Part II MECHANISMS OF AUTOIMMUNITY The possibility that an individual s immune system may react against autologous antigens and cause tissue injury
More informationSupplementary Figure 1 Dosage correlation between imputed and genotyped alleles Imputed dosages (0 to 2) of 2-digit alleles (red) and 4-digit alleles
Supplementary Figure 1 Dosage correlation between imputed and genotyped alleles Imputed dosages (0 to 2) of 2-digit alleles (red) and 4-digit alleles (green) of (A) HLA-A, HLA-B, (C) HLA-C, (D) HLA-DQA1,
More informationThe HLA-DQA1 and HLA-DQB1 alleles and haplotypes of two Brazilian Indian tribes. Evidences of conservative evolution of HLA-DQ.
Reference: Sotomaior VS, Faucz FR, Schafhauser C, Janzen-Dück M, Boldt AB, Petzl-Erler ML. HLA- DQA1 and HLA-DQB1 alleles and haplotypes in two Brazilian Indian tribes: evidence of conservative evolution
More informationTHE HUMAN LEUKOCYTE antigen (HLA) haplotype
0021-972X/00/$03.00/0 Vol. 85, No. 3 The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright 2000 by The Endocrine Society Islet Cell Antibody-Positive Relatives with Human Leukocyte
More informationSignificance of the MHC
CHAPTER 7 Major Histocompatibility Complex (MHC) What is is MHC? HLA H-2 Minor histocompatibility antigens Peter Gorer & George Sneell (1940) Significance of the MHC role in immune response role in organ
More informationHLA class II gene frequencies in Crohn's disease:
538 Gut 1996; 38: 538-542 HLA class II gene frequencies in Crohn's disease: a population based analysis in Germany Department of Medicine I, University of Ulm, Germany M Reinshagen U Weiss B J Manfras
More informationBasel - 6 September J.-M. Tiercy National Reference Laboratory for Histocompatibility (LNRH) University Hospital Geneva
Basel - 6 eptember 2012 J.-M. Tiercy National Reference Laboratory for Histocompatibility (LNRH) University Hospital Geneva Outline the HLA system is (a) complex anti-hla immunisation and alloreactivity
More informationClinical Performance of Roche COBAS 4800 HPV Test
JCM Accepts, published online ahead of print on 9 April 2014 J. Clin. Microbiol. doi:10.1128/jcm.00883-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 1 2 3 4 5 6 Clinical
More informationExtensive studies on polymerase chain reactionsequence-specific. DRB1* allele profiling in non insulin dependent diabetes mellitus (Indian population)
African Journal of Pharmacy and Pharmacology Vol. 6(10), pp. 685-691, 15 March, 2012 Available online at http://www.academicjournals.org/ajpp DOI: 10.5897/AJPP11.052 ISSN 1996-0816 2012 Academic Journals
More informationCHAPTER 3 LABORATORY PROCEDURES
CHAPTER 3 LABORATORY PROCEDURES CHAPTER 3 LABORATORY PROCEDURES 3.1 HLA TYPING Molecular HLA typing will be performed for all donor cord blood units and patients in the three reference laboratories identified
More informationPart XI Type 1 Diabetes
Part XI Type 1 Diabetes Introduction Åke Lernmark Epidemiology Type 1 diabetes is increasing worldwide and shows epidemic proportions in several countries or regions [1]. There is evidence to suggest that
More informationPatient Consult Report
Patient Consult Report Clinical History Currently 36 years old History of firstborn son now about 5 years old followed by secondary recurrent pregnancy loss with 9 losses (all between 6 and 11 weeks) over
More information1. INTRODUCTION. Profile of HLA-DQ allele in a sample of Iraqi Celiac disease Patients. ABSTRACT
Profile of HLA-DQ allele in a sample of Iraqi Celiac disease Patients. Noor Sabah Haphed 1, Ekhlass N.Ali 2 and Batool Mutar Mahdi 3 1, 2, PDepartment of Biology, College of Science, AL-Mustansyria University,
More informationEffects of age-at-diagnosis and duration of diabetes on GADA and IA-2A positivity
Effects of age-at-diagnosis and duration of diabetes on GADA and IA-2A positivity Duration of diabetes was inversely correlated with age-at-diagnosis (ρ=-0.13). However, as backward stepwise regression
More informationUse of PCR with Sequence-specific Primers for High-Resolution Human Leukocyte Antigen Typing of Patients with Narcolepsy
Original Article Woo HI, et al. Diagnostic Immunology Ann Lab Med 2012;32:57-65 ISSN 2234-3806 eissn 2234-3814 Use of PCR with Sequence-specific Primers for High-Resolution Human Leukocyte Antigen Typing
More informationMA Binotto, L Guilherme, and AC Tanaka. Rheumatic Fever. Images Paediatr Cardiol Apr-Jun; 4(2):
IMAGES in PAEDIATRIC CARDIOLOGY Images Paediatr Cardiol. 2002 Apr-Jun; PMCID: PMC3232519 Rheumatic Fever MA Binotto, L Guilherme, and AC Tanaka Heart Institute (InCor), University of Sao Paulo Medical
More informationThe Role of Human Leukocyte Antigen (HLA) Complex in IBD: Crohn s Disease. and Ulcerative Colitis
Advanced Studies in Biology, Vol. 1, 2009, no. 1, 37-41 The Role of Human Leukocyte Antigen (HLA) Complex in IBD: Crohn s Disease and Ulcerative Colitis Manuel Muro, Ruth López, José A. Campillo, *Hortensia
More informationHLA-DR2 and IKBL+738(C) in Dutch Ulcerative Colitis Patients
HLA-DR2 and IKBL+738(C) in Dutch Ulcerative Colitis Patients Boukje de Vries Student from the VUmc Amsterdam The Netherlands September 2002 January 2003 Supervisors: EG de la Concha, AS Peña, L Fernandez
More informationHLA TYPING AND EXPRESSION: POTENTIAL MARKER FOR IDENTIFYING EARLY DYSPLASIA AND STRATIFYING THE RISK FOR IBD-CANCER
HLA TYPING AND EXPRESSION: POTENTIAL MARKER FOR IDENTIFYING EARLY DYSPLASIA AND STRATIFYING THE RISK FOR IBD-CANCER Megan Garrity, S. Breanndan Moore, M.D., William Sandborn, M.D., Vernon Pankratz, Ph.D.,
More informationDistinctive HLA-II association with primary biliary cholangitis on the Island of Sardinia
Original Article Distinctive HLA-II association with primary biliary cholangitis on the Island of Sardinia United European Gastroenterology Journal 2017, Vol. 5(4) 527 531! Author(s) 2016 Reprints and
More informationFULL PAPER Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease
(2004) 5, 381 388 & 2004 Nature Publishing Group All rights reserved 1466-4879/04 $30.00 www.nature.com/gene FULL PAPER Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations
More informationAutoimmunity & Transplantation. Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel:
Autoimmunity & Transplantation Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa Learning Objectives By the end of this lecture you will be able to: 1 Recognize
More informationImmunology Lecture 4. Clinical Relevance of the Immune System
Immunology Lecture 4 The Well Patient: How innate and adaptive immune responses maintain health - 13, pg 169-181, 191-195. Immune Deficiency - 15 Autoimmunity - 16 Transplantation - 17, pg 260-270 Tumor
More informationspecific PCR-based HLA class II typing
288 28 Clin Pathol 1997;50:288-293 Department of Histopathology, Southampton General Hospital, Southampton, United Kingdom A C Bateman J M Theaker Wessex Histocompatibility Laboratory, Southampton, United
More informationCardiovascular Disease in Africa and Beyond
Global Health and Disasters course 21 October 2016 Cardiovascular Disease in Africa and Beyond Ed Havranek, MD Denver Health Medical Center University of Colorado School of Medicine Medical Education Partnership
More informationHLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol
HLA and antigen presentation Department of Immunology Charles University, 2nd Medical School University Hospital Motol MHC in adaptive immunity Characteristics Specificity Innate For structures shared
More informationFONS Nové sekvenační technologie vklinickédiagnostice?
FONS 2010 Nové sekvenační technologie vklinickédiagnostice? Sekvenování amplikonů Sequence capture Celogenomové sekvenování FONS 2010 Sekvenování amplikonů Amplicon sequencing - amplicon sequencing enables
More informationImmunogenetics in SARS: a casecontrol
RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES MHL Ng 吳香玲 SH Cheng 鄭淑恆 KM Lau 劉建盟 GM Leung 梁卓偉 US Khoo 邱瑋璇 BCW Zee 徐仲鍈 JJY Sung 沈祖堯 Key Messages 1. Human leukocyte antigen (HLA) genotypes from 102
More informationHOST-PARASITE INTERPLAY
HOST-PARASITE INTERPLAY Adriano Casulli EURLP, ISS (Rome, Italy) HOST-PARASITE INTERPLAY WP3 (parasite virulence vs human immunity) (Parasite) Task 3.1: Genotypic characterization Task 3.6: Transcriptome
More information